Summary
Human E-cadherin is a homophilic cell adhesion molecule and its expression is well preserved in normal human hepatocytes; a decrease in its expression has been observed in poorly differentiated hepatocellular carcinoma cells. We examined the alteration of E-cadherin and catenin expressions caused by differentiation inducers in human hepatocellular carcinoma cells. Hepatocellular carcinoma cell lines, HCC-T and HCC-M, were cultured with all-trans retinoic acid (ATRA), dexamethasone (DEX), sodium butyrate, and interferon-α. E-cadherin expression was only up-regulated by butyrate and interferon-α (IFN-α) in both cell lines, studied by means of fluorescence immunostaining and flow cytometry. The localization of E-cadherin staining was shown at their cell membrane. According to the increase in E-cadherin expression, β-catenin expression appeared at the cell membrane of both cell lines when treated with butyrate and IFN-α. Such an appearance was not observed when cells were treated with ATRA and DEX. Western blotting showed that α-and γ-catenin expression was not changed, while only the expression of β-catenin increased. β-Catenin oncogenic activation as a result of amino acid substitutions or interstitial deletions within or including parts of exon 3, which has been demonstrated recently, was not detected in these cell lines by direct deoxyribonucleic acid sequencing. These results suggest that the expression and interaction between E-cadherin and wild-type β-catenin are potentially modulated by butyrate and IFN-α, and that these two agents are potent inhibitors of hepatocellular carcinoma cell invasion and metastasis.
Similar content being viewed by others
References
Aberle, H.; Buiz, S.; Stappert, J., et al. Assembly of the cadherin-catenin complex in vitro with recombinant proteins. J. Cell Sci. 107:3655–3663; 1994.
Byers, S.; Pishvaian, M.; Crockett, C., et al. Retinoids increase cell-cell adhesion strength, β-catenin protein stability, and localization to the cell membrane in a breast cancer cell line: a role for serine kinase activity. Endocrinology 137:3265–3273; 1996.
Ebinuma, H.; Saito, H.; Saito, Y., et al. Antisense oligodeoxynucleotide against c-myc mRNA induces differentiation of human hepatocellular carcinoma cells. Int. J. Oncol. 15:991–999; 1999.
Funayama N.; Fagotto, F.; McCrea, P.; Gumbiner, B. Embryonic axis induction by the armadillo repeat domain of β-catenin: evidence for intracellular signaling. J. Cell Biol. 128:959–968; 1995.
Hinck, L.; Näthke, I. S.; Papkoff, J.; Nelson, W. J. Dynamics of cadherin/catenin complex formation: novel protein interactions and pathways of complex assembly. J. Cell Biol. 125:1327–1340; 1994.
Hirano, S.; Kimoto, N.; Shimoyama, Y., et al. Identification of a neural α-catenin as a key regulator of cadherin function and multicellular organization. Cell 70:293–301; 1992.
Ihara, A.; Koizumi, H.; Hashizume, R.; Uchikoshi, T. Expression of epithelial cadherin and alpha- and beta-catenins in nontumoral livers and hepatocellular carcinomas. Hepatology 23:1441–1447; 1996.
Ilan, Y.; Saito, H.; Thummala, N. R., et al. Adenovirus-mediated gene therapy of liver diseases. Semin Liver Dis. 19:49–59; 1999.
Jawkari, A.; Jordan, S.; Poole, S., et al. Abnormal immunoreactivity of the E-cadherin-catenin complex in gastric carcinoma: relationship with patient survival. Gastroenterology 112:46–54; 1997.
Jou, T. S.; Stewart, D. B.; Stappert, J., et al. Genetic and biochemical dissection of protein linkages in the cadherin-catenin complex. Proc. Natl. Acad. Sci. USA 92:5067–5071; 1995.
Koch, A.; Denkhaus, D.; Alberecht, S., et al. Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the β-catenin gene. Cancer Res. 59:269–273; 1999.
Kozyraki, R.; Scoazec, J. Y.; Flejou, J. F., et al. Expression of cadherins and alpha-catenin in primary epithelial tumors of the liver. Gastroenterology 110:1137–1149; 1996.
Leung, M.-F.; Lin, T. S.; Sartorelli, A. C. Changes in actin and actin-binding proteins during the differentiation of HL-60 leukemia cells. Cancer Res. 52:3063–3066; 1992.
Mareel, M. M.; Behrens, J.; Birchmeier, W., et al. Down-regulation of E-cadherin expression in Madin Darby canine kidney (MDCK) cells inside tumors of nude mice. Int. J. Cancer 47:922–928; 1991.
Matarrese, P.; Giandomenico, V.; Fiorucci, G., et al. Antiproliferative activity of interferon a and retinoic acid in SiHa carcinoma cells: the role of cell adhesion. Int. J. Cancer 76:531–540; 1998.
Miyoshi, Y.; Iwao, K.; Nagasawa, Y., et al. Activation of the β-catenin gene in primary hepatocellular carcinoma by somatic alterations involving exon 3. Cancer Res. 58:2524–2527; 1998.
Morton, R. A.; Ewing, C. M.; Nagafuchi, A., et al. Reduction of E-cadherin levels and deletion of the α-catenin gene in human prostate cancer cells. Cancer Res. 53:3585–3590; 1993.
Nagafuchi, A.; Takeichi, M. Trasmembrane control of cadherin-mediated cell adhesion: a 94-kDa protein functionally associated with a specific region of the cytoplasmic domain of E-cadherin. Cell Regul. 1:37–44; 1989.
Oyama, T.; Kanai, Y.; Ochiai, A., et al. A truncated β-catenin disrupts the interaction between E-cadherin and α-catenin: a cause of loss of intercellular adhesiveness in human cancer cell lines. Cancer Res. 54: 6282–6287; 1994.
Ozawa, M.; Baribault, H.; Kemler, R. The cytoplasmic domain of the cell adhesion molecule uvomorulin associates with three independent proteins structurally related in different species. EMBO J. 8:1711–1717; 1989.
Pavalko, F. M.; Otey, C. A. Role of adhesion molecule cytoplasmic domains in mediating interactions with the cytoskeleton. Proc. Soc. Exp. Biol. Med. 205:282–293; 1994.
Perimon, N. The genetic basis of patterned baldness in Drosophila. Cell 76: 781–784; 1994.
Polakis, P. The oncogenic activation of beta-catenin. Curr. Opin. Genet. Dev. 9:15–21; 1999.
Saito, H.; Ebinuma, H.; Takahashi, M., et al. Loss of butyrate-induced apoptosis in human hepatocellular carcinoma cell lines HCC-M and HCC-T having substantial Bcl-2 expression. Hepatology 27:1233–1240; 1998.
Saito, H.; Kagawa, T.; Tada, S., et al. Effect of dexamethasone, dimethyl-sulfoxide and sodium butyrate on a human hepatocellular carcinoma cell line PLC/PRF/5. Cancer Biochem. Biophys. 13:75–84; 1992.
Saito, H.; Morizane, T.; Watanabe, T., et al. Establishment of a human cell line (HCC-T) from a patient with hepatocellular carcinoma bearing no evidence of hepatitis B or A virus infection. Cancer 64:1054–1060; 1989.
Saito, H.; Morizane, T.; Watanabe, T., et al. Differentiating effect of sodium butyrate on human hepatocellular carcinoma cell lines PLC/PRF/5, HCC-M and HCC-T. Int. J. Cancer 48:291–296; 1991.
Saito, H.; Tada, S.; Ebinuma, H., et al. Changes of antigen expression on human hepatocellular carcinoma cell lines caused by sodium butyrate, a differentiation inducer. J. Gastroenterol. 29:733–739; 1994.
Saunders, N.; Dicker, A.; Popa, C., et al. Histone deacetylase inhibitors as potential anti-skin cancer agents. Cancer Res. 59:399–404; 1999.
Schipper, J. H.; Unger, A.; Jahnke, K. E-cadherin as a functional marker of the differentiation and invasiveness of squamous cell carcinoma of the head and neck. Clin. Otolaryngol. 19:381–384; 1994.
Shimamura, K.; Takahashi, T.; Takeichi, T. E-cadherin expression in a particular subset of sensory neurons. Dev. Biol. 152:242–254; 1992.
Shimazui, T.; Schalken, J. A.; Giroldi, L. A., et al. Prognostic values of cadherin-associated molecules (α-, β-, and γ-catenin and p120cas) in bladder tumors. Cancer Res. 56:4154–4158; 1996.
Shimoyama, Y.; Hirohashi, S.; Hirano, S. et al. Cadherin cell-adhesion molecules in human epithelial tissues and carcinomas. Cancer Res. 49: 2128–2133; 1989.
Shimoyama, Y.; Hirohashi, S. Cadherin intercellular adhesion molecule in hepatocellular carcinomas: loss of E-cadherin expression in an undifferentiated carcinoma. Cancer Lett. 57:131–135; 1991.
Späth, G. F.; Weiss, M. C. Hepatocyte nuclear factor 4 provokes expression of epithelial marker genes, acting as a morphogen in dedifferentiated hepatocellular carcinoma cells. J. Cell. Biol. 140:935–946; 1998.
Tabibzadeh, S.; Kong, Q. F.; Kapur, S., et al. Tumor necrosis factor-α-mediated dyscohesion of epithelial cells associated with disordered expression of cadherin/β-catenin and assembly of actin filaments Hum. Reprod. 10:994–1004; 1995.
Tada, S.; Saito, H.; Ebinuma, H., et al. Reduction of LAK-sensitivity and changes in antigen expression on hepatoma cells by sodium butyrate. Cancer Biochem. Biophys. 15:177–186; 1996.
Tada, S.; Saito, H.; Tsunematsu, S., et al. Interferon regulatory factor-1 gene abnormality and loss of growth inhibitory effect of interferon-α in human hepatoma cell lines. Int. J. Oncol. 13:1207–1216; 1998.
Takeichi, M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science 251:1451–1455; 1991.
Takeichi, M. Cadherin in cancer: implications for invasion and metastasis. Curr. Opin. Cell Biol. 5:806–811; 1993.
Watabe, M.; Nagafuchi, A.; Tsukita, S., et al. Induction of polarized cell-cell association and retardation of growth by activation of the E-cadherin-catenin adhesion system in a dispersed carcinoma line. J. Cell Biol. 127:247–256; 1994.
Watanabe, T.; Morizane, T.; Tsuchimoto, K., et al. Establishment of a cell line (HCC-M) from a human hepatocellular carcinoma. Int. J. Cancer 32: 141–146; 1983.
van der Wurff, A. A. M.; Arends, J.-W.; van der Linden, E. P. M., et al. L-CAM expression in lymph node and liver metastases of colorectal carcinomas. J. Pathol. 172:177–182; 1994.
Zetter, B. R. Adhesion molecules in tumor metastasis. Semin. Cancer Biol. 4:219–229; 1993.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Masuda, T., Saito, H., Kaneko, F. et al. Up-regulation of E-cadherin and β-catenin in human hepatocellular carcinoma cell lines by sodium butyrate and interferon-α. In Vitro Cell.Dev.Biol.-Animal 36, 387–394 (2000). https://doi.org/10.1290/1071-2690(2000)036<0387:UROECA>2.0.CO;2
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1290/1071-2690(2000)036<0387:UROECA>2.0.CO;2